Adenosine deaminase deficiency: Genotype-phenotype correlations based on expressed activity of 29 mutant alleles

American Journal of Human Genetics

Volumn 63, Issue 4, 1998, Pages 1049-1059

  Arredondo Vega, Francisco X ^a   Santisteban, Ines ^a   Daniels, Shannon ^a   Toutain, Stephan ^a   Hershfield, Michael S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DEOXYADENOSINE DERIVATIVE; NUCLEOTIDE DERIVATIVE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HUMAN; IMMUNE DEFICIENCY; INFANT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; NEWBORN; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL;

ADA; ESCHERICHIA COLI;

EID: 0032231355     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302054     Document Type: Article

References (56)

1. Akeson AL, Wiginton DA, Dusing MR, States JC, Hutton JJ (1988) Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts. J Biol Chem 263: 16291-16296
2. Akeson AL, Wiginton DA, States JC, Perme CM, Dusing MR, Hutton JJ (1987) Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing. Proc Natl Acad Sci USA 84:5947-5951
3. Arredondo-Vega FX, Kurtzberg J, Chaffee S, Santisteban I, Reisner E, Povey MS, Hershfield MS (1990) Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combined immunodeficiency. J Clin Invest 86:444-452
4. Arredondo-Vega FX, Santisteban T, Kelly S, Schlossman CM, Umetsu DT, Hershfield MS (1994) Correct splicing despite mutation of the invariant first nucleotide of a 5′ splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency. Am J Hum Genet 54: 820-830
5. Arredondo-Vega FX, Santisteban I, Notarangelo LD, El Dahr J, Buckley R, Roifman C, Conley ME, et al (1998) Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Hum Mutat 11:482
6. Atasoy U, Norby-Slycord CJ, Markert ME (1993) A missense mutation in exon 4 of the human adenosine deaminase gene causes severe combined immunodeficiency. Hum Mol Genet 2:1307-1308
7. Bagnara AS, Hershfield MS (1982) Mechanism of deoxyaden-osine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells. Proc Natl Acad Sci USA 79:2673-2677
8. Bollinger ME, Arredondo-Vega FX, Santisteban I, Schwarz K, Hershfield MS, Lederman HM (1996) Hepatic dysfunction as a complication of adenosine deaminase (ADA) deficiency. N Engl J Med 334:1367-1371
9. Bonthron DT, Markham AF, Ginsberg D, Orkin SH (1985) Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency. J Clin Invest 76:894-897
10. Bory C, Boulieu R, Souillet G, Chantin C, Rolland MO, Mathieu M, Hershfield MS (1990) Comparison of red cell transfusion and polyethylene glycol-modified adenosine deaminase therapy in an adenosine deaminase-deficient child. Pediatr Res 28:127-130
11. Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, Roberts JE, et al (1997) Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130: 378-387
12. Chang ZY, Nygaard P, Chinault AC, Kellems RE (1991) Deduced amino acid sequence of Escherichia coli adenosine deaminase reveals evolutionarily conserved amino acid residues: implications for catalytic function. Biochemistry 30: 2273-2280
13. Cohen A, Hirschhorn R, Horowitz SD, Rubinstein A, Polmar SH, Hong R, Martin DW Jr (1978) Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci USA 75:472-475
14. Daddona PE, Davidson BE, Perignon JE, Kelley WN (1985) Genetic expression in partial adenosine deaminase deficiency: mRNA levels and protein turnover for the enzyme variants in human B-lymphoblast cell lines. J Biol Chem 260: 3875-3880
15. Geffner ME, Stiehm ER, Stephure D, Cowan MJ (1986) Probable autoimmune thyroid disease and combined immunodeficiency disease. Am J Dis Child 140:1194-1196
16. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067-1069
17. Gossage DL, Norby-Slycord CJ, Hershfield MS, Markert ML (1993) A homozygous five nucleotide deletion in the adenosine deaminase (ADA) mRNA in a child with ADA deficiency and very low levels of ADA mRNA and protein. Hum Mol Genet 2:1493-1494
18. Hershfield MS, Buckley RH, Greenberg ML, Melton AL, Schiff R, Hatem C, Kurtzberg J, et al (1987) Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med 316:589-596
19. Hershfield MS, Chaffee S, Sorensen RU (1993) Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy. Pediatr Res Suppl 33:S42-S48
20. Hershfield MS, Mitchell BS (1995) Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver CR, Beaudet al, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th ed. McGraw-Hill, New York, pp 1725-1768
21. Hirschhorn R (1979) Clinical delineation of adenosine deaminase deficiency. In: Elliot K, Whelan J (eds) Enzyme defects and immune dysfunction, Ciba Foundation Symposium 68. Exerpta Medica, New York, pp 35-54
22. _ (1992) Identification of two new missense mutations (R156C and S291L) in two ADA-SCID patients unusual for response to therapy with partial exchange transfusions. Hum Mutat 1:166-168
23. _ (1995) Adenosine deaminase deficiency: molecular basis and recent developments. Clin Immunol Immunopathol Suppl 76:S219-S227
24. Hirschhorn R, Borkowsky W, Jiang CK, Yang DR, Jenkins T (1997) Two newly identified mutations (Thr 233Ile and Leu 152Met) in partial adenosine deaminase-deficient (ADA-) individuals that result in differing biochemical and metabolic phenotypes. Hum Genet 100:22-29
25. Hirschhorn R, Chakravarti V, Puck J, Douglas SD (1991) Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID). Am J Hum Genet 49:878-885
26. Hirschhorn R, Ellenbogen A (1986) Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency. Am J Hum Genet 38:13-25
27. Hirschhorn R, Nicknam MN, Eng F, Yang DR, Borkowsky W (1992) Novel deletion and a new missense mutation (Glu217Lys) at the catalytic site in two adenosine deaminase (ADA) alleles of a patient with neonatal onset ADA-severe combined immunodeficiency. J Immunol 149:3107-3112
28. Hirschhorn R, Roegner V, Jenkins T, Seaman C, Piomelli S, Borkowsky W (1979) Erythrocyte adenosine deaminase deficiency without immunodeficiency: evidence for an unstable mutant enzyme. J Clin Invest 64:1130-1139
29. Hirschhorn R, Tzall S, Ellenbogen A (1990) Hot spot mutations in adenosine deaminase deficiency. Proc Natl Acad Sci USA 87:6171-6175
30. Hirschhorn R, Yang DR, Insel RA, Ballow M (1993) Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro). Cell Immunol 152:383-393
31. Hirschhorn R, Yang DR, Israni A, Huie ML, Ownby DR (1994) Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery. Am J Hum Genet 55:59-68
32. Hirschhorn R, Yang DR, Puck JM, Huie ML, Jiang C-K, Kurlandsky LE (1996) Spontaneous reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 13:290-295
33. Hove-Jensen B, Nygaard P (1989) Role of guanosine kinase in the utilization of guanosine for nucleotide synthesis in Escherichia coli. J Gen Microbiol 135:1263-1273
34. Ibrahim MM, Weber IT, Knudsen TB (1995) Mutagenesis of human adenosine deaminase to active forms that partially resist inhibition by pentostatin. Biochem Biophys Res Commun 209:407-416
35. Jenkins T, Rabson AR, Nurse GT, Lane AB (1976) Deficiency of adenosine deaminase not associated with severe combined immunodeficiency. J Pediatr 89:732-736
36. Jochimsen B, Nygaard P, Vestergaard T (1975) Location on the chromosome of Escherichia coli of genes governing purine metabolism: adenosine deaminase (add), guanosine kinase (gsk) and hypoxanthine phosphoribosyltransferase (hpt). Mol Gen Genet 143:85-91
37. Levy Y, Hershfield MS, Fernandez-Mejia C, Polmar SH, Scudiery D, Berger M, Sorensen RU (1988) Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase (PEG-ADA). J Pediatr 113:312-317
38. Markert ML, Hershfield MS, Schiff RI, Buckley RH (1987) Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients. J Clin Immunol 7:389-399
39. Markert ML, Hutton JJ, Wiginton DA, States JC, Kaufman RE (1988) Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements. J Clin Invest 81:1323-1327
40. Migchielsen AAJ, Breuer ML, van Roon MA, te Riele H, Zurcher C, Ossendorp F, Toutain S, et al (1995) Adenosine deaminase-deficient mice die perinatally, exhibiting liver-cell degeneration, small intestinal cell death, and lung atelectasis. Nat Genet 10:279-287
41. Ozsahin H, Arredondo-Vega FX, Santisteban I, Fuhrer H, Tuchschmid P, Jochum W, Aguzzi A, et al (1997) Adenosine deaminase (ADA) deficiency in adults. Blood 89:2849-2855
42. Santisteban I, Arredondo-Vega FX, Kelly S, Debré M, Fischer A, Pérignon JL, Hilman B, et al (1995a) Four new adenosine deaminase mutations, altering a zinc-binding histidine, two conserved alanines, and a 5′ splice site. Hum Mutat 5: 243-250
43. Santisteban I, Arredondo-Vega FX, Kelly S, Loubser M, Mey dan N, Roifman C, Howell PL, et al (1995b) Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum Mol Genet 4:2081-2087
44. Santisteban I, Arredondo-Vega FX, Kelly S, Mary A, Fischer A, Hummell DS, Lawton A, et al (1993) Novel splicing, missense, and deletion mutations in 7 adenosine deaminase deficient patients with late/delayed onset of combined immunodeficiency disease: contribution of genotype to phenotype. J Clin Invest 92:2291-2302
45. Shovlin CL, Hughes JMB, Simmonds HA, Fairbanks L, Deacock S, Lechler R, Roberts I, et al (1993) Adult presentation of adenosine deaminase deficiency. Lancet 341:1471
46. Shovlin CL, Simmonds HA, Fairbanks L, Deacock S, Hughes JMB, Lechler R, Webster ADB, et al (1994) Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency. J Immunol 153:2331-2339
47. Siaw MFE, Mitchell BS, Koller CA, Coleman MS, Hutton JJ (1980) ATP depletion as a consequence of adenosine deaminase inhibition in man. Proc Natl Acad Sci USA 77: 6157-6161
48. Spencer N, Hopkinson DA, Harris H (1968) Adenosine deaminase polymorphism in man. Ann Hum Genet 32:9-15
49. Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint-Basile G, Durandy A, et al (1993) Severe combined immunodeficiency: a retrospective single center study of clinical presentation and outcome in 117 patients. J Pediatr 123: 564-572
50. Umetsu DT, Schlossman CM, Ochs HD, Hershfield MS (1994) Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency. J Allergy Clin Immunol 93:543-550
51. Wakamiya M, Blackburn MR, Jurecic R, McArthur MJ, Geske RS, Cartwright J Jr, Mitani K, et al (1995) Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc Natl Acad Sci USA 92:3673-3677
52. Weinberg K, Hershfield MS, Bastian J, Kohn D, Sender L, Parkman R, Lenarsky C (1993) T lymphocyte ontogeny in adenosine deaminase deficient severe combined immune deficiency following treatment with polyethylene glycol modified adenosine deaminase. J Clin Invest 92:596-602
53. Wiginton DA, Adrian GS, Hutton JJ (1984) Sequence of human adenosine deaminase cDNA including the coding region and a small intron. Nucleic Acids Res 12:2439-2446
54. Wiginton DA, Hutton JJ (1982) Immunoreactive protein in adenosine deaminase deficient human lymphoblast cell lines. J Biol Chem 257:3211-3217
55. Wiginton DA, Kaplan DJ, States JC, Akeson AL, Perme CM, Bilyk IJ, Vaughn AJ, et al (1986) Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry 25:8234-8244
56. Wilson DK, Rudolph FB, Quiocho FA (1991) Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science 252:1278-1284